Jun 14, 2018
Overwhelming Success of First International NASH Day Paves Way for a Promising Edition In 2019
Jun 12, 2018
Today, First International NASH Day: A First of its Kind Call to Action for Patients, Individuals at Risk, Medical Staff and Media
Jun 11, 2018
D-1 Before First Ever International NASH Day: Detailed Program Announcement & Liver Forum Endorsement
Jun 05, 2018
NASH - A Silent Killer: 150 World Experts Sign a Global Call to Action to Promote Awareness of Deadly Liver Disease
May 31, 2018
Green Park Collaborative, The Forum for Collaborative Research, and the Obesity Action Coalition (OAC) Launch coreNASH to Develop Consensus on Critical Outcomes in Non-Alcoholic Steatohepatitis (NASH) Clinical Research
May 22, 2018
International NASH Day Adds Trusted Stakeholders as Global Day of Action Against Fatty Liver Diseases Draws Near
Apr 12, 2018
The NASH Education Program: 1st International NASH Day Coalition Accelerates Globally, Adding Major Industrial Partners and Patient Advocacy Groups
Apr 06, 2018
The Nonalcoholic Steatohepatitis (NASH) Network in Collaboration with The Kinetix Group Participates in The International Liver Congress 2018
Mar 26, 2018
The NASH Education Program(TM), Giving Voice to the "Silent Epidemic" Afflicting 25 Million Americans, Launches in the United States on March 26
Feb 07, 2018
Galmed Granted "Preferred Technological Enterprise" Status Which may Provide the Company With Significant Financial Benefits
Nov 21, 2017
NAFLD/NASH Diagnosis is Unexpected to People Not Aware of This Rising Epidemic
Oct 19, 2017
Boehringer Ingelheim partners with TARGET PharmaSolutions to Progress NASH Research
Oct 13, 2017
Intercept (ICPT) Extends Strategic Partnership with TARGET PharmaSolutions for TARGET-NASH
Oct 12, 2017
Bristol-Myers Squibb (BMY) Extends Strategic Partnership with TARGET PharmaSolutions for TARGET-NASH
Oct 10, 2017
Non-Alcoholic Steatohepatitis Drugs Market (NASH) Trends, Size, Growth, Opportunities and 2026 Forecast Report
Oct 05, 2017
HistoIndex Receives Frost & Sullivan 2017 Asia-Pacific Best Practices Award for Innovative Diagnostics in the Area of Nonalcoholic Steatohepatitis (NASH)
Aug 18, 2017
NASH (Non-alcoholic Steatohepatitis) Biomarkers Market to Reach $2 Billion by 2025: Increasing Incidence of Chronic Liver Diseases is Expected to Propel Demand in this Market